The Lancet Publishes Commentary On AMR Benchmark

The Lancet publishes commentary on AMR Benchmark

A new Commentary published today in The Lancet discusses the potential of the new Antimicrobial Resistance Benchmark to stimulate pharmaceutical companies to limit antimicrobial resistance. The Commentary has been co-authored by Jayasree K. Iyer, Executive Director of the Access to Medicine Foundation, and Marc Mendelson, Professor of Infectious Diseases and Head of the Division of Infectious Diseases & HIV Medicine, Groote Schuur Hospital, University of Cape Town, South Africa.
Continue reading
New: Latest Framework For Action By Pharmaceutical Companies On Access To Medicine

New: latest framework for action by pharmaceutical companies on access to medicine

Today, the Access to Medicine Foundation has published the methodology for the 2018 Access to Medicine Index. It pinpoints where pharmaceutical companies have the greatest potential for improving access to medicine in low- and middle-income countries.
Continue reading
Now Online: First Independent Framework For Assessing Pharma Company Action On AMR

Now online: first independent framework for assessing pharma company action on AMR

Today, the Access to Medicine Foundation publishes the methodology for its 2018 Antimicrobial Resistance Benchmark. It is the first independently developed framework for evaluating how pharmaceutical companies are taking action to limit antimicrobial resistance (AMR).
Continue reading
Online Soon: New Methodology For Antimicrobial Resistance Benchmark

Online soon: new methodology for Antimicrobial Resistance Benchmark

The Access to Medicine Foundation will shortly publish the methodology for a new tool – an Antimicrobial Resistance Benchmark that will evaluate how pharmaceutical companies are responding to the increase in drug resistance. The AMR Benchmark is funded by the UK and Dutch Ministry of Health, Welfare and Sport.
Continue reading
New Study Finds Wide Variety In Pharma Companies’ Cancer Access Programmes

New study finds wide variety in pharma companies’ cancer access programmes

The Access to Medicine Foundation has systematically mapped how large research-based pharmaceutical companies are responding to the growing cancer crisis in low and lower-middle income countries.
Continue reading
The Access To Medicine Foundation Has Moved!

The Access to Medicine Foundation has moved!

The Access to Medicine Foundation has outgrown its former office in Haarlem and moved to a larger space in Amsterdam. The new office is close to the Amsterdam Sloterdijk station on Naritaweg 227-A, 1043 CB, Amsterdam.
Continue reading
Out Now: The First Access To Vaccines Index

Out now: the first Access to Vaccines Index

The first Access to Vaccines Index will be published on Monday 6 March, 2017. It is the first tool of its kind to present the current landscape of vaccine company behaviour when it comes to making vaccines more accessible for the populations that need them.
Continue reading
Out In March: The First Access To Vaccines Index

Out in March: the first Access to Vaccines Index

The first Access to Vaccines Index will be published on Monday 6 March, 2017. It is the first tool of its kind to present the current landscape of vaccine company behaviour when it comes to making vaccines more accessible for the populations that need them.
Continue reading
Foundation To Track Pharma Company Progress On AMR

Foundation to track pharma company progress on AMR

The Access to Medicine Foundation has started work on a new tool – an Antimicrobial Resistance Benchmark that will track how pharmaceutical companies are responding to the increase in drug-resistance. The AMR Benchmark is currently funded by the UK and Dutch governments.
Continue reading
Coming Up: 2016 Access To Medicine Index To Launch In UK At Houses Of Parliament

Coming up: 2016 Access to Medicine Index to launch in UK at Houses of Parliament

On Tuesday 6 December, members of the UK parliament will co-host the UK launch of the 2016 Access to Medicine Index. The event will focus on UK-based pharmaceutical companies and the role of government in improving access to medicine for the world’s poorest.
Continue reading
New Analysis: Large Pharmaceutical Companies Are Developing Five HIV/AIDS Medicines For Children

New analysis: large pharmaceutical companies are developing five HIV/AIDS medicines for children

For World AIDS Day 2016, the Access to Medicine Foundation has analysed the pharmaceutical pipelines for HIV/AIDS from 20 of the world’s largest pharmaceutical companies. Out of 51 high-burden diseases and conditions, HIV/AIDS is one of the five diseases getting the most R&D attention. Today, they have five projects in the pipeline aimed at children.
Continue reading
New Online: 2016 Access To Medicine Index

New online: 2016 Access to Medicine Index

The new 2016 Access to Medicine Index finds that pharmaceutical companies are getting more sophisticated in the way they get products to poor people and are addressing global health priorities. However, good practice is limited to a narrow range of products and countries. Opportunities to expand such targeting of efforts are yet to be realised.
Continue reading
2016 Index: From Findings To Change

2016 Index: from findings to change

Following the publication of the 2016 Access to Medicine Index, the Foundation team has begun a series of meetings and events to discuss its findings and the new ranking of pharmaceutical companies. This includes a panel discussion at the FT Pharmaceutical and Biotechnology Conference in London, followed by investor meetings in London, Paris, Basel and New York.
Continue reading
Which Pharmaceutical Companies Have The Most Essential Medicines And Vaccines?

Which pharmaceutical companies have the most essential medicines and vaccines?

The new analysis by the Access to Medicine Foundation shows which large pharmaceutical companies are marketing the most essential medicines and vaccines for the highest-burden disease in developing countries. It matches companies’ on market portfolio for 50 conditions and diseases with the WHO Model Essential Medicine List.
Continue reading
UNICEF Covers The Upcoming Access To Vaccines Index

UNICEF covers the upcoming Access to Vaccines Index

Margot de Graaff from the UNICEF Netherlands magazine interviews Jayasree K Iyer and Suzanne Wolf regarding the pharmaceutical industry, the Access to Medicines Index and the upcoming Access to Vaccines Index.
Continue reading
2016 Access To Medicine Index: Out In November

2016 Access to Medicine Index: out in November

The Access to Medicine Foundation is preparing a new iteration of its leading sustainability Index of pharmaceutical companies – the next Access to Medicine Index will be published in November 2016.
Continue reading
AMR And Access To Cancer Medicine, Discussing The Role Of The Pharma Industry

AMR and Access to Cancer Medicine, discussing the role of the pharma industry

Jayasree K. Iyer will participate in two key events on the role of the pharmaceutical industry regarding access to antimicrobials and AMR, and in improving access to cancer medication. She will speak at the UN General Assembly side event on AMR; and at the Royal Society of Medicine on access to cancer medicine.
Continue reading
Jayasree K. Iyer To Chair Panel On Barriers To NCDs In Sub-Saharan Africa

Jayasree K. Iyer to chair panel on barriers to NCDs in sub-Saharan Africa

On 26 August in Nairobi, African leaders and the Japanese government will come together to discuss trade, investment and development at TICAD VI. In a TICAD side-event, Jayasree K. Iyer, will chair a panel discussion about the challenge of treating non-communicable diseases in sub-Saharan Africa.
Continue reading
Now Online: Going Beyond CSR To Reach ‘the Two Billion’ By Jayasree K. Iyer For PharmaPhorum

Now online: Going beyond CSR to reach ‘the two billion’ by Jayasree K. Iyer for PharmaPhorum

Many pharma companies have corporate social responsibility (CSR) departments, but some are going further and putting access to medicine at the core of their businesses. Jayasree K. Iyer, considers how this trend is helping treatments reach the two billion people around the world who lack medicines at present.
Continue reading
Access To Vaccines Index: The Data Is In, Analysis Can Begin.

Access to Vaccines Index: the data is in, analysis can begin.

The Access to Medicine Foundation is introducing a new tool for action: the Access to Vaccines Index will examine how vaccine developers and manufacturers are improving access to vaccines.
Continue reading
Ongoing Dialogue: With Japanese Pharma Industry And At OECD Responsible Business Forum

Ongoing dialogue: with Japanese pharma industry and at OECD Responsible Business Forum

Jayasree K. Iyer, will be in Tokyo to follow up on the Foundation’s recent dialogue with Japanese pharmaceutical companies, and to meet with representatives of the Japanese Ministry of Foreign Affairs and the Ministry of Health. A central item on Jayasree's itinerary is the 2016 Annual Partners Meeting of the Global Health Innovative Technology Fund (GHIT).
Continue reading
The Access To Medicine Foundation At The 69th WHO World Health Assembly

The Access to Medicine Foundation at the 69th WHO World Health Assembly

The WHO’s annual World Health Assembly (WHA) draws the greatest minds working on global health. This year, Jayasree K. Iyer, Executive Director, together with Research Programme Manager Tara Prasad, will be joining on behalf of the Access to Medicine Foundation. They will participate in a series of meetings and bring their expertise on how to encourage pharmaceutical companies to do more in access to medicine.
Continue reading
Data Collection In Progress For The 2016 Access To Medicine Index

Data collection in progress for the 2016 Access to Medicine Index

The world’s top 20 pharmaceutical companies are now submitting data for the 2016 Access to Medicine Index, on the measures they are taking to improve access to medicine. The 2016 Index will explore how companies are shifting from commitment-making to action-taking when it comes to ensuring medicines and vaccines are within the reach of the world’s global poor.
Continue reading
How The Access To Medicine Index Inspires Stronger Action By Pharma Companies

How the Access to Medicine Index inspires stronger action by pharma companies

An Independent Impact Evaluation concludes that the Access to Medicine Index is a catalyst and inspiration for pharma companies to do more for the two billion people who lack access to medicine. Findings show that the Access to Medicine Index has contributed to change
Continue reading
Dialogue On Access To Medicine With Japanese Pharma Companies

Dialogue on Access to Medicine with Japanese pharma companies

The Access to Medicine Foundation will be visiting Tokyo, Japan from 12 to 15 January, for a series of meetings with Japan-based pharmaceutical companies and other key stakeholders working towards improving access to medicine worldwide.
Continue reading
Dutch TV Show Koffietijd Broadcasts Interview With Suzanne Wolf On Access To Vaccines For Children

Dutch TV show Koffietijd broadcasts interview with Suzanne Wolf on access to vaccines for children

On the popular Dutch TV show Koffietijd (Coffeetime) presenter Pernille La Lau interviewed Suzanne Wolf, Director of Communications at the Access to Medicine Foundation about how vaccines save lives and protect children from the threat of disease.
Continue reading
A New Catalyst For Change: Methodology For The First Access To Vaccines Index

A new catalyst for change: methodology for the first Access to Vaccines Index

The Access to Medicine Foundation is introducing a new tool for action – the Access to Vaccines Index. It will analyse how vaccine companies are improving access to high-priority vaccines for communities in need.
Continue reading
The Bulletin Of WHO Publishes An Article On The Thematic Study: Hepatitis C By The Access To Medicine Foundation

The Bulletin of WHO publishes an article on the thematic study: hepatitis C by the Access to Medicine Foundation

The Bulletin of the World Health Organization has published the latest study from the Access to Medicine Foundation: on how the world’s largest pharma companies are improving access to hepatitis C treatment. These companies have an opportunity to play a central role in curbing, and perhaps ending, a global epidemic.
Continue reading
Pharmaceutical Companies Come To Amsterdam: Workshop On Latest Index Methodology

Pharmaceutical companies come to Amsterdam: workshop on latest Index methodology

On 18 and 19 November, the Access to Medicine Foundation will run a workshop in Amsterdam for 20 of the world’s largest pharmaceutical companies with a role to play in improving access to medicine. Over 40 company representatives are coming to Amsterdam for the workshop, from across Europe, Japan and the US.
Continue reading
2016 Access To Medicine Index To Place High Emphasis On How Pharmaceutical Companies Perform

2016 Access to Medicine Index to place high emphasis on how pharmaceutical companies perform

Globally, 2 billion people still cannot access the medicine they need. The world’s leading pharmaceutical companies have an important role to play in improving this situation. The Access to Medicine Foundation has published its latest methodology for benchmarking companies’ efforts here. The methodology for the 2016 Access to Medicine Index places greater emphasis on company performance.
Continue reading
Jayasree K. Iyer Becomes Executive Director Of The Access To Medicine Foundation

Jayasree K. Iyer becomes Executive Director of the Access to Medicine Foundation

As of October, 2015, Jayasree K. Iyer is Executive Director of the Access to Medicine Foundation, taking over from Wim Leereveld. Wim Leereveld will join the Foundation’s Supervisory Board.
Continue reading
Coming Up: Speaking Engagements & Events – Open Invitation

Coming up: speaking engagements & events – open invitation

In the coming weeks, come and join Wim Leereveld, CEO, and Jayasree K. Iyer, Head of Research, from the Access to Medicine Foundation, at a series of public events to discuss access to medicine and the role for pharmaceutical companies.
Continue reading
Consensus Emerges On Approach For Improving Access To Vaccines

Consensus emerges on approach for improving access to vaccines

After talking to the major stakeholders in the vaccines ecosystem, the Access to Medicine Foundation is now crystallising consensus on how vaccine companies can best approach access to vaccines. This goes hand in hand with the finalisation of metrics for the Access to Vaccines Index, the first in-depth exploration of how vaccine companies are making immunisation more accessible.
Continue reading
Catch-up: How Do Pharma Companies Support MDG5?

Catch-up: How do pharma companies support MDG5?

Catch-up with the web discussion co-convened by the Access to Medicine Foundation, the UN Foundation and Family Planning 2020 about how pharmaceutical companies’ are improving access to maternal health and contraception. The discussion centers on a landscape study recently published by the Access to Medicine Foundation.
Continue reading
2015 Methodology Review: Independent Experts Meet To Evaluate Next Index Methodology

2015 Methodology Review: independent experts meet to evaluate next Index methodology

On 17 June, the Expert Review Committee will gather in Haarlem to review key methodology proposals for the next Access to Medicine Index and the first Access to Vaccines Index.
Continue reading
2015 Methodology Review: Targeting Key Aspects Of The Index Analysis

2015 Methodology Review: targeting key aspects of the Index analysis

The 2015 Methodology Review began in January with a series of checks on the analytical approach used for the 2014 Access to Medicine Index. During the course of the year, the research team will align the methodology with changes in access-to-medicine priorities and how pharmaceutical companies can make products more available, accessible and affordable. The final methodology will be published in November 2015.
Continue reading
Access To Vaccines Index: Introducing The First Principles

Access to Vaccines Index: introducing the first principles

The Access to Vaccines Index methodology is currently being developed, with support from stakeholders and vaccine experts. Its first principles will be introduced on 20 May in Amsterdam. The first Access to Vaccines Index is planned for publication early in 2017.
Continue reading
New Research: How Pharmaceutical Companies Address Access To Maternal And Reproductive Health

New Research: How pharmaceutical companies address access to maternal and reproductive health

Every day, an estimated 800 women die during pregnancy and childbirth due to preventable causes – most of whom live in developing countries. Today, the Access to Medicine Foundation publishes the first landscape study of pharmaceutical companies’ responses to MDG 5 to help improve this situation.
Continue reading
April 9: WHO Seminar On Access To Medicine Index; BioPharma Sustainability Roundtable

April 9: WHO seminar on Access to Medicine Index; BioPharma Sustainability Roundtable

In April, representatives of the Access to Medicine Foundation have been invited to lead a WHO seminar in Geneva and speak at the BioPharma Sustainability Roundtable in Cambridge, USA.
Continue reading
Pharma Companies Discuss 2014 Index Performances

Pharma companies discuss 2014 Index performances

The 2014 Access to Medicine Index identifies clear opportunities for pharmaceutical companies to improve access to their products. During a month of individual evaluation sessions, companies and the Index team discuss critical steps on the path ahead.
Continue reading
Access To Medicine Index Receives Funds From The Postcode Loterij

Access to Medicine Index receives funds from the Postcode Loterij

The Postcode Loterij in the Netherlands has awarded one of its 2015 annual grants to the Access to Medicine Foundation. The cheque was presented at the Postcode Loterij’s annual ‘Goed Geld Gala’ event in Amsterdam on 26 January.
Continue reading
Recap: Launch Of The 2014 Access To Medicine Index

Recap: launch of the 2014 Access to Medicine Index

In the three months since its publication, the 2014 Access to Medicine Index report has been welcomed as a balanced and detailed report on pharmaceutical company activity regarding access to medicine by the diverse groups active in this area. The new 2014 ranking and findings have been covered widely in global media outlets, including the Financial Times, Reuters, the Wall Street Journal and Die Welt, as well as in industry-focused titles, such as PharmaTimes, Scrip and the Pharmaceutical Journal.
Continue reading
2014 Access To Medicine Index At The European Parliament – Open Invitation

2014 Access to Medicine Index at the European Parliament – open invitation

On 4 February, the 2014 Access to Medicine Index will be launched at the European Parliament in Brussels by Wim Leereveld, Index CEO and founder, and Jayasree K. Iyer, Index Head of Research. Jay Iyer, will present the latest ranking of the top 20 global pharmaceutical companies, giving insight into where these companies are focusing and innovating, particularly when it comes to R&D.
Continue reading
Davos 2015: Wim Leereveld On Health Systems Design

Davos 2015: Wim Leereveld on health systems design

On January 22, during the World Economic Forum Annual Meeting, Index CEO and founder Wim Leereveld will be in Davos to discuss health systems leap-frogging in emerging economies. In a private session organised by the World Economic Forum, supported by the Boston Consulting Group.
Continue reading

Sign up to receive updates about our work.